Literature DB >> 11024471

Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein.

E Graner1, A F Mercadante, S M Zanata, V R Martins, D G Jay, R R Brentani.   

Abstract

Prions, the etiological agents for infectious degenerative encephalopathies, act by inducing structural modifications in the cellular prion protein (PrPc). Recently, we demonstrated that PrPc binds laminin (LN) and that this interaction is important for the neuritogenesis of cultured hippocampal neurons. Here we have used the PC-12 cell model to explore the biological role of LN-PrPc interaction. Antibodies against PrPc inhibit cell adhesion to LN-coated culture plaques. Furthermore, chromophore-assisted laser inactivation of cell surface PrPc perturbs LN-induced differentiation and promotes retraction of mature neurites. These results point out to the importance of PrPc as a cell surface ligand for LN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024471     DOI: 10.1016/s0014-5793(00)02070-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Cellular prion protein: implications in seizures and epilepsy.

Authors:  Roger Walz; Rosa Maria R P S Castro; Tonicarlo R Velasco; Carlos G Carlotti; Américo C Sakamoto; Ricardo R Brentani; Vilma R Martins
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.

Authors:  Silvio M Zanata; Marilene H Lopes; Adriana F Mercadante; Glaucia N M Hajj; Luciana B Chiarini; Regina Nomizo; Adriana R O Freitas; Ana L B Cabral; Kil S Lee; Maria A Juliano; Elizabeth de Oliveira; Saul G Jachieri; Alma Burlingame; Lan Huang; Rafael Linden; Ricardo R Brentani; Vilma R Martins
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

3.  Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1.

Authors:  Flavio H Beraldo; Camila P Arantes; Tiago G Santos; Nicolle G T Queiroz; Kirk Young; R Jane Rylett; Regina P Markus; Marco A M Prado; Vilma R Martins
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 4.  Is, indeed, the prion protein a Harlequin servant of "many" masters?

Authors:  M Catia Sorgato; Caterina Peggion; Alessandro Bertoli
Journal:  Prion       Date:  2009-10-04       Impact factor: 3.931

Review 5.  De novo mammalian prion synthesis.

Authors:  Federico Benetti; Giuseppe Legname
Journal:  Prion       Date:  2009-10-26       Impact factor: 3.931

6.  Prion protein expression and functional importance in skeletal muscle.

Authors:  Jeffrey D Smith; Jennifer S Moylan; Brian J Hardin; Melissa A Chambers; Steven Estus; Glenn C Telling; Michael B Reid
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

Review 7.  The cellular prion protein (PrP(C)): its physiological function and role in disease.

Authors:  Laura Westergard; Heather M Christensen; David A Harris
Journal:  Biochim Biophys Acta       Date:  2007-03-02

8.  Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke.

Authors:  Woei-Cherng Shyu; Demeral David Liu; Shinn-Zong Lin; Wen-Wen Li; Ching-Yuan Su; Ying-Chen Chang; Hsiao-Jung Wang; Hsing-Won Wang; Chang-Hai Tsai; Hung Li
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 9.  Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases.

Authors:  Shao-Chih Chiu; Huey-Shan Hung; Shinn-Zong Lin; Esheral Chiang; Demeral David Liu
Journal:  J Mol Med (Berl)       Date:  2009-09-10       Impact factor: 4.599

10.  The cellular prion protein interacts with the tissue non-specific alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells.

Authors:  Myriam Ermonval; Anne Baudry; Florence Baychelier; Elodie Pradines; Mathéa Pietri; Kimimitsu Oda; Benoît Schneider; Sophie Mouillet-Richard; Jean-Marie Launay; Odile Kellermann
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.